S-606001 matching placebo, S-606001
2405N1221
Phase 2 small_molecule active
Quick answer
S-606001 matching placebo, S-606001 for Late-onset Pompe disease. is a Phase 2 program (small_molecule) at Shionogi B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Shionogi B.V.
- Indication
- Late-onset Pompe disease.
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active